-Manfred Schmitt Researcher Activity Profile

Research Author Detailed Information 

Manfred Schmitt Publication Rate By Year

Manfred Schmitt has published 4 paper(s) in 2003, 2 paper(s) in 2006, 1 paper(s) in 2007, 5 paper(s) in 2008, for a total of 12 research publications in total.

Manfred M Schmitt Author Information

LAST NAME: schmitt

FIRST NAME: manfred

INITIALS: M

AFFILIATION:

Papers

Manfred Schmitt's Publication Record

1. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma. Year Published: 2006
Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.
2. Biomechanical and immunohistochemical analysis of high hydrostatic pressure-treated Achilles tendons. Year Published: 2006
Department of Orthopedic Surgery, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
3. Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer. Year Published: 2007
4. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Year Published: 2008
Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
5. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: Comparison to antigen quantification by ELISA. Year Published: 2008
Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany.
6. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Year Published: 2008
Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
7. The urokinase receptor (uPAR, CD87) as a target for tumor therapy: uPA-silica particles (SP-uPA) as a new tool for assessing synthetic peptides to interfere with uPA/uPA-receptor interaction. Year Published: 2003
Klinische Forschergruppe, Frauenklinik, Technische Universität München, 81675 Munich, Germany.
8. Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo. Year Published: 2003
Klinische Forschergruppe der Frauenklinik der TU München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany.
9. Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance. Year Published: 2003
Klinische Forschergruppe der Frauenklinik, Technische Universität München, Ismaninger Strasse 22, 81675 Munich, Germany.
10. Advanced statistical methods for the definition of new staging models. Year Published: 2003
Klinische Forschergruppe der Frauenklinik, Technische Universität München, Ismaningerstr. 22, 81675 Munich, Germany.
11. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Year Published: 2008
Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany.
12. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Year Published: 2008
Department of Obstetrics and Gynecology, Technical University of Munich, Ismaninger Str. 22, D-81675 Munich, Germany.